Micrus Endovascular to Present at the Canaccord Cardiovascular Conference

SAN JOSE, Calif.--(BUSINESS WIRE)--Micrus Endovascular Corporation (NASDAQ: MEND) today announced that Robert Stern, President and Chief Operating Officer, will present at the third annual Canaccord Cardiovascular Conference on Tuesday, November 10, 2009, at 4:00 p.m. Pacific time (7:00 p.m. Eastern time) at the Hotel Nikko in San Francisco.

Live webcast of the conference presentations will be available via the Internet by visiting the Investor Relations section of Micrus’ Web site at www.micruscorp.com. An archive of these presentations will be available on the Web site for 14 days.

About Micrus Endovascular Corporation

Micrus develops, manufactures and markets implantable and disposable medical devices for use in the treatment of cerebral vascular diseases. Micrus products are used by interventional neuroradiologists, interventional neurologists and endovascularly trained neurosurgeons to treat both cerebral aneurysms responsible for hemorrhagic stroke and intracranial atherosclerosis, which may lead to ischemic stroke. Hemorrhagic and ischemic stroke are both significant causes of death and disability worldwide. The Micrus product lines enable physicians to gain access to the brain in a minimally invasive manner through the vessels of the arterial system. Micrus’ proprietary, three-dimensional microcoils anatomically deploy within the aneurysm, forming a scaffold that conforms to a wide diversity of aneurysm shapes and sizes. Micrus also sells stents, balloon catheters, access devices such as guide catheters, microcatheters, guidewires and accessory products used in conjunction with its microcoils. For more information, visit www.micruscorp.com.